Edited by Simon Barraclough (deputy editor) and Dr Hans Lofgren, from the School of International and Political Studies, Deakin University Victoria
Collection published: 1 June 2007
Debate
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal
Thomas A Faunce Australia and New Zealand Health Policy 2007, 4:9 (1 June 2007)
Abstract | Full text | PDF | PubMed
'Linkage' pharmaceutical evergreening in Canada and Australia
Thomas A Faunce, Joel Lexchin Australia and New Zealand Health Policy 2007, 4:8 (1 June 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
Commentary
Generic drug policy in Australia: a community pharmacy perspective
Grahame Beecroft Australia and New Zealand Health Policy 2007, 4:7 (1 June 2007)
Reshaping Australian drug policy: the dilemmas of generic medicines policy
Hans Löfgren Australia and New Zealand Health Policy 2007, 4:11 (1 June 2007)
Research
The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy
Hans Löfgren Australia and New Zealand Health Policy 2007, 4:10 (1 June 2007)
